KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 128 filers reported holding KURA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,036,000 | +6.6% | 62,331 | 0.0% | 0.50% | -11.7% |
Q3 2020 | $1,910,000 | +88.0% | 62,331 | 0.0% | 0.57% | +67.0% |
Q2 2020 | $1,016,000 | -27.4% | 62,331 | -55.7% | 0.34% | -42.3% |
Q1 2020 | $1,400,000 | -23.1% | 140,705 | +6.3% | 0.59% | -8.3% |
Q4 2019 | $1,820,000 | +0.9% | 132,344 | +8.2% | 0.64% | -6.7% |
Q3 2019 | $1,804,000 | -10.8% | 122,273 | +19.6% | 0.69% | -7.3% |
Q2 2019 | $2,022,000 | +9.8% | 102,198 | -25.3% | 0.74% | -9.2% |
Q1 2019 | $1,841,000 | 0.0% | 136,767 | 0.0% | 0.82% | +3.7% |
Q4 2018 | $1,841,000 | +9.5% | 136,767 | +41.9% | 0.79% | +36.4% |
Q3 2018 | $1,681,000 | +0.8% | 96,352 | 0.0% | 0.58% | -6.3% |
Q2 2018 | $1,667,000 | +11.5% | 96,352 | +20.8% | 0.62% | +0.2% |
Q1 2018 | $1,495,000 | – | 79,752 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |